Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary

2.10 Vascular disease

Checked: not set yet by Next Review: not set yet

2.10 Vascular disease

First line drugs Second line drugs Specialist drugs Secondary care drugs


Peripheral vascular disease


5HT2 Receptor Antagonists

Naftidrofuryl oxalate

  • For the treatment of intermittent claudication in people with peripheral arterial disease in according to NICE guidance TA223